Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS)

NCT03690206 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Short Bowel Syndrome

Interventions

DRUG: glepaglutide
DRUG: Placebo

Sponsor

Zealand Pharma